Foreign Sales Yield Positive Results For Recordati

August 2008 | Company News Alert

An increasing foreign presence for Italy's Recordati has helped limit the impact of a stagnant domestic market and post positive pharmaceutical sales results for H108, up by 10.0% year-on-year (y-o-y) to EUR331.5mn (US$516.0mn). Net income also climbed by 16.7% to EUR52.4mn (US$81.6mn), of which EUR8.3mn was capital gain from the divestment in its Portuguese operations in June. The firm confirmed its objectives for the year, expecting total revenues (up 8.6% in H108) to rise by

If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.